Guidelines on the Availment of the Special Leave Benefits for Women Under R.A. 9710 (An Act Providing for the Magna Carta of Women)
OCA Circular No. 83-11 outlines the guidelines for female public sector employees in the Philippines regarding the special leave benefits for those who have undergone surgery due to gynecological disorders, as stipulated in the Magna Carta of Women (R.A. 9710). Eligible employees can avail of a maximum of two months of special leave with full pay, provided they have served at least six months in government agencies within the previous year. The guidelines specify the application process, including the requirement for medical certification, and categorize surgical procedures into minor and major based on recuperation time. Additionally, the special leave benefit is non-cumulative and cannot be converted to cash. These provisions aim to promote reproductive health care and ensure equitable treatment for women in the public sector.
June 28, 2011
OCA CIRCULAR NO. 83-11
| TO | : | All Judges and Personnel of the Lower Courts |
| SUBJECT | : | Guidelines on the Availment of the Special Leave Benefits for Women Under R.A. 9710 (An Act Providing for the Magna Carta of Women) |
For the information and guidance of all concerned, quoted hereunder is the pertinent portion of CSC MC No. 25, s. 2010, to wit:
"Pursuant to CSC Resolution No. 1000432 dated November 22, 2010, the following Guidelines for the Availment of the Special Leave Benefits for Women under R.A. 9710 (An Act Providing for the Magna Carta of Women) are hereby prescribed for the guidance of all concerned:
1.0 Purpose
1.1 To provide further guidelines on the availment of special leave benefits for qualified female public sector employees who have undergone surgery caused by gynecological disorders pursuant to the provisions and implementing rules and regulations of the Magna Carta of Women.
1.2 To ensure the uniform interpretation and implementation of the grant of the special leave benefits for women and ensure that the availment of the same ultimately upholds the objectives of the Law. aHADTC
2.0 Guidelines on Entitlement to the Special Leave Benefits for Women
2.1 Any female public sector employee regardless of age and civil status, shall be entitled to a special leave of a maximum of two (2) months with full pay based on her gross monthly compensation, provided she has rendered at least six (6) months aggregate service in any or various government agencies for the last twelve (12) months prior to undergoing surgery for gynecological disorders.
2.1.1 The special leave privilege may be availed for every instance of gynecological disorder requiring surgery for a maximum period of two (2) months per year.
2.2 Generally, availment of the said special leave benefits shall be in accordance with the attached List of Surgical Operations for Gynecological Disorders (Annex A), which reflects, among others, the estimated periods of recuperation from surgery due to the specific gynecological disorder.
2.2.1 The said List of Surgical Operations for Gynecological Disorders reflects, among others a classification of the Procedure based on the patient's estimated period of recuperation, defined as follows:
|
Classification of the
|
Description
|
|
Procedure based on the
|
|
|
Patient's Estimated Period
|
|
|
of Recuperation if without
|
|
|
concomitant medical
|
|
|
problems
|
|
| Minor | Surgical Procedures |
| requiring a maximum | |
| period of recuperation | |
| of two (2) weeks | |
| Major | Surgical Procedures |
| requiring a minimum | |
| period of recuperation | |
| of three (3) weeks to a | |
| maximum period of | |
| two (2) months |
2.2.2 Other Surgical Operations for Gynecological Disorders which are not found in Annex A of this Guidelines may be allowed subject to certification of a competent medical authority and submission of other requirements provided under item 3.1 hereof.
2.3 The earned leave credits may be used for preparatory procedures and/or confinement prior to the surgery. Moreover, should the period of recuperation after the surgery exceed two (2) months, the female official/employee may use her earned sick leave credits for the same. If the sick leave credits have been exhausted, the vacation leave credits may be used pursuant to Section 56 of the Omnibus Rules on Leave. SECcIH
2.4 This special leave benefit is non-cumulative and not convertible to cash.
3.0 Procedure for Availment of the Special Leave Benefits for Women
3.1 The application for the special leave benefit shall be made through the Civil Service Form No. 6 (CS Form 6) signed by the employee and approved by the proper signing authorities.
3.2 The CS Form 6 shall be accompanied by a medical certificate filled out by the proper medical authorities, e.g., the attending surgeon accompanied by a clinical summary reflecting the gynecological disorder which shall be addressed or was addressed by the said surgery; the histopathological report; the operative technique used for the surgery; the duration of the surgery including the peri-operative period (period of confinement around surgery); as well as the employee's estimated period of recuperation for the same.
3.3 The application for the special leave benefits may be applied for in advance, that is, at least five (5) days prior to the scheduled date of the gynecological surgery that will be undergone by the employee. The rest of the requirements specified in item 3.2 shall be attached to the medical certificate upon the employee's return to work under Item 3.5 of this Guidelines.
The advance notice for taking such leave would give the proper authorities ample time and means to prevent the disruption of the operations of the work unit during the absence of the employee and to address the exigency of services of the office.
3.4 In instances when a qualified female employee undergoes an emergency surgical procedure, the said leave application shall be filed immediately upon the employee's return from such leave also following the procedure set forth in Item 3.1 and 3.2 of this Guidelines.
3.5 Upon the employee's return to work, she shall also present a medical certificate signed by her attending surgeon that she is physically fit to assume the duties of her position.
4.0 Responsibilities of the Agency Head
4.1 The agency head shall ensure that the aforecited guidelines are enforced in one's agency as a mechanism in order that female employee's right to proper reproductive health care is ensured.
4.2 The agency head shall promote reproductive health care awareness and wellness program for its employees through proactive measure/s such as conduct of annual physical/medical check-up, information campaign on maintaining proper reproductive health care; issuance of health advisories; distribution of educational reading materials and conduct of fora relative to the same. IcHSCT
5.0 Effectivity
These Guidelines shall take effect retroactively starting September 15, 2009 or fifteen (15) days after the publication of the Magna Carta of Women.
Government officials and employees covered in these Guidelines whose periods of surgery and recuperation due to gynecological disorders after the effectivity of the Magna Carta of Women and before the promulgation of these Guidelines were deducted against their sick or vacation leave credits can have the said leave credits restored and/or appropriate gross compensation paid, as the case may be."
Please be guided accordingly.
(SGD.) JOSE MIDAS P. MARQUEZCourt AdministratorOffice of the Court Administrator
ANNEX A
List of Surgical Operations for Gynecological Disorders
Vulva, Perineum, and Introitus
|
Procedure
|
Disease
|
Classification *
|
|
| Incision and drainage of vulvar or |
Vulvar or perineal abscess
|
Minor
|
|
| perineal abscess/masses |
|
|
|
| Incision and drainage of Bartholin's |
Bartholin's gland abscess
|
Minor
|
|
| gland abscess |
|
|
|
| Marsupialization of Bartholin's |
Bartholin's gland cyst
|
Minor
|
|
| gland cyst |
|
|
|
| Lysis of labial adhesions |
Labial adhesions
|
Minor
|
|
| Biopsy of vulvar or perineal |
Vulvar warts
|
Minor
|
|
| masses |
Vulvar Masses
|
|
|
| Electracautery of vulvar warts |
Vulvar warts
|
Minor
|
|
| Vulvectomy simple; partial |
Vulvar masses
|
Major
|
|
| or complete |
|
|
|
| Vulvectomy, radical, partial; |
Vulvar carcinoma
|
Major
|
|
| with unilateral inguinofemoral |
|
|
|
| lymphadenectomy |
|
|
|
| with bilateral inguinofemoral |
|
|
|
| lymphadenectomy |
|
|
|
| Vulvectomy, radical, complete; |
Vulvar carcinoma
|
Major
|
|
| with unilateral inguinofemoral |
|
|
|
| lymphadenectomy |
|
|
|
| with bilateral inguinofemoral |
|
||
| lymphadenectomy |
|
||
| Vulvectomy, radical, complete, with |
Vulvar carcinoma
|
Major
|
|
| inguinofemoral, iliac, and pelvic |
|
|
|
| lymphadenectomy |
|
|
|
| Partial hymenectomy or revision of |
Imperforate hymen
|
Minor
|
|
| hymenal ring |
|
|
|
| Hymonectomy, simple incision |
Imperforate hymen
|
Minor
|
|
| Excision of Bartholin's gland or cyst |
Bartholin's gland
|
Minor
|
|
|
cyst/abscess
|
|
||
| Vagina |
|
|
|
|
Procedure
|
Disease
|
Classification
|
|
| Biopsy of vaginal mucosa and/or |
Vaginal warts, vaginal
|
Minor
|
|
| masses |
masses
|
|
|
| Colpocleisis (Le Fort type) |
Uterine prolapse
|
Major
|
|
| Excision of vaginal septum |
Transverse vaginal septum
|
Minor
|
|
| Excision of vaginal cyst or tumor |
Vaginal cyst
|
Minor
|
|
|
Vaginal masses
|
|
||
| Insertion of uterine tandems and/or |
Cervical or endometrial
|
Minor
|
|
| vaginal ovoids for clinical |
cancer
|
|
|
| brachytherapy |
|
|
|
| Colporrhapy, suture of injury of |
Trauma
|
Minor
|
|
| vagina (nonobsterical) |
|
|
|
| Colpoperineorrhapy, suture of |
Trauma
|
Minor
|
|
| injury of vagina and/or perineum |
|
|
|
| (nonobsterical) |
|
|
|
| Plastic operation on urethral |
Urethrocele
|
Minor
|
|
| sphincter, vaginal approach (e.g., |
|
|
|
| Kelly urethral plication) |
|
|
|
| Plastic repair of urethrocele |
Urethrocele
|
Minor
|
|
| Anterior and/or posterior |
Cysto+/-urethrocele
|
Major
|
|
| colporrhaphy |
|
|
|
| Anterior and/or posterior |
Rectocele
|
Major
|
|
| colporrhaphy, with or w/o |
|
|
|
| perineorrhapy |
|
|
|
| Combined anteroposterior |
Cystocoele with rectocele
|
Major
|
|
| colporrhaphy |
|
|
|
| With enterocele repair |
Pelvic organ prolapsed
|
Major
|
|
| Repair of enterocele, vaginal |
Pelvic organ prolapsed
|
Major
|
|
| approach |
|
|
|
| Repair of enterocele, Abdominal |
Pelvic organ prolapsed
|
Major
|
|
| approach |
|
|
|
| Colpopexy, abdominal approach |
Pelvic organ prolapsed
|
Major
|
|
| Sacrospinous ligament fixation |
Pelvic organ prolapsed
|
Major
|
|
| for prolapse of vagina |
|
|
|
| Prespinous on Iliococcygeal |
Pelvic organ prolapsed
|
Major
|
|
| ligament fixation |
|
|
|
| Paravaginal defect repair (including |
Pelvic organ prolapsed
|
Major
|
|
| repair of cystocele, stress urinary |
|
|
|
| incontinence, and/or incomplete |
|
|
|
| vaginal prolapse) |
|
|
|
| Sling operation for stress |
Urinary stress
|
Major
|
|
| incontinence (e.g., fascia or |
incontinence
|
|
|
| synthetic) |
|
|
|
| Burch calposuspension/retroposbic |
Urinary stress
|
Major
|
|
| urethroprosy |
incontinence
|
|
|
| Pereyra procedure, including |
Urinary stress
|
Major
|
|
| anterior colporrhapy |
incontinence
|
|
|
| Repair of rectovaginal fistula, |
Rectovaginal fistula
|
Major
|
|
| vaginal or transanal approach |
|
|
|
| abdominal approach |
Rectovaginal fistula
|
Major
|
|
| abdominal approach, with |
Rectovaginal fistula
|
Major
|
|
| concomitant colostomy |
|
|
|
| Repair of urethrovaginal fistula; |
Urethrovaginal fistula
|
Major
|
|
| with bulbocavernosus transplant |
|
Major
|
|
| Repair of vesicovaginal fistula; |
Vesicovaginal fistula
|
Major
|
|
| vaginal approach |
|
|
|
| transvesical and vaginal |
|
|
|
| approach |
|
|
|
| Removal of impacted vaginal |
Retained foreign body
|
Minor
|
|
| foreign body under anesthesia |
|
|
|
| Laparoscopy, surgical, colpopexy |
Pelvic organ prolapsed
|
Major
|
|
| (suspension of vaginal apex) |
|
|
|
| Colposcopy (Vaginoscopy) |
Vaginal intraepithelial lesions
|
Minor
|
|
| Colposcopy; with biopsy(s) |
Vaginal and cervical
|
Minor
|
|
| of the cervix and/or endocervical |
intraepithelial lesions
|
|
|
| curettage |
|
|
|
| Colposcopy; with loop electrode |
Cervical intraepithelial
|
Minor
|
|
| excision procedure of the cervix |
lesions
|
|
|
| Cervix |
|
|
|
|
Procedure
|
Disease
|
Classification
|
|
| Cervical Biopsy, single or multiple, |
Cervical pathology
|
Minor
|
|
| or local excision of lesion, with or |
|
|
|
| w/o fulguration |
|
|
|
| Cauterization of cervix; any |
Cervical warts
|
Minor
|
|
| method |
|
|
|
| Conization of cervix, with or w/o |
Cervical intraepithelial
|
Minor
|
|
| fulguration, with or w/o dilation |
neoplasia
|
|
|
| and curettage, with or w/o repair; |
|
|
|
| cold knife or laser loop electrode |
|
|
|
| excision |
|
|
|
| Trachelectomy (cervicectomy), |
Cervical masses
|
Major
|
|
| amputation of cervix |
|
|
|
| Excision of cervical stump, |
S/p subtotal hysterectomy
|
Major
|
|
| abdominal approach; with or |
|
|
|
| w/o pelvic floor repair |
|
|
|
| Excision of cervical stump, |
S/p subtotal hysterectomy
|
Major
|
|
| vaginal approach; with anterior |
+/- pelvic organ prolapse
|
|
|
| and/or posterior repair with |
|
|
|
| repair of entercele |
|
|
|
| Trachelorrhaphy, plastic repair |
Cervical lacerations
|
Minor
|
|
| of uterine cervix, vaginal |
|
|
|
| approach |
|
|
|
| Cerclage of cervix, during |
Cervical incompetence
|
Major
|
|
| pregnancy; vaginal abdominal |
|
|
|
| Hysterorrhaphy of ruptured uterus |
Cervical incompetence
|
Major
|
|
| Uterus |
|
|
|
|
Procedure
|
Disease
|
Classification
|
|
| Endometrial sampling (biopsy) |
Uterine Pathologies
|
Minor
|
|
| with or w/o endocervical sampling |
|
|
|
| (biopsy), w/o cervical dilation, |
|
|
|
| any method |
|
|
|
| Dilation and curettage |
Uterine Pathologies
|
Minor
|
|
| Vaginal Myomectomy, excision of |
Uterine Pathologies
|
Minor
|
|
| fibroid tumor of uterus, single or |
|
|
|
| multiple |
|
|
|
| Myomectomy, excision of fibroid |
Uterine Pathologies
|
Major
|
|
| tumor of uterus, single or multiple; |
|
|
|
| abdominal approach |
|
|
|
| Total abdominal hysterectomy |
Uterine, ovarian and
|
Major
|
|
| (corpus and cervix), with or w/o |
fallopian pathologies
|
|
|
| removal of tube(s), with or w/o |
|
|
|
| removal ovary(s) |
|
|
|
| Supracervical abdominal |
Uterine, ovarian and
|
Major
|
|
| hysterectomy (subtotal |
fallopian tube pathologies
|
|
|
| hysterectomy), with or w/o |
|
|
|
| removal of tube(s), with or w/o |
|
|
|
| removal of ovary(s) |
|
|
|
| Total abdominal hysterectomy, |
Uterine, ovarian, fallopian
|
Major
|
|
| including partial vaginectomy, with |
tube malignancies
|
|
|
| para-aortic and pelvic lymph node |
|
|
|
| sampling, with or w/o removal of |
|
|
|
| tube(s), with or w/o removal of |
|
|
|
| ovary(s) |
|
|
|
| Radical abdominal hysterectomy, |
Uterine, ovarian
|
Major
|
|
| with bilateral total pelvic |
malignancies
|
|
|
| lymphadenectomy and para-aortic |
|
|
|
| lymph node sampling (biopsy), |
|
|
|
| with or w/o removal of tube(s), |
|
|
|
| with or w/o removal of ovary(s) |
|
|
|
| Pelvic exenteration for gynecologic |
Uterine, ovarian, fallopian
|
Major
|
|
| malignancy, with total abdominal |
tube malignancies
|
|
|
| hysterectomy or cervicectomy, |
|
|
|
| with or w/o removal of tube(s), |
|
|
|
| with or w/o removal of ovary(s), |
|
|
|
| with removal of bladder and |
|
|
|
| ureteral transplantations, and/or |
|
|
|
| abdominoperineal resection of |
|
|
|
| rectum and colon and colostomy, |
|
|
|
| or any combination thereof. |
|
|
|
| Vaginal hysterectomy; |
Pelvic organ prolapse/stress
|
Major
|
|
|
urinary incontinence
|
|
||
| with removal of tube(s), and/or |
Pelvic organ prolapse/stress
|
Major
|
|
| ovary(s) |
urinary incontinence
|
|
|
| with removal of tube(s), and/or |
Pelvic organ prolapse/stress
|
Major
|
|
| ovary(s), with repair of enterocele |
urinary incontinence
|
|
|
| with colpo-urethrocystopexy |
Pelvic organ prolapse/stress
|
Major
|
|
| (Marshall-Marchetti-Krantz type, |
urinary incontinence
|
|
|
| Pereyra type, with or w/o |
|
|
|
| endoscopic control) |
|
|
|
| with repair of enterocele |
Pelvic organ prolapse/stress
|
Major
|
|
|
urinary incontinence
|
|
||
| Vaginal hysterectomy; with total or |
Pelvic organ prolapse/stress
|
Major
|
|
| partial colpectomy |
urinary incontinence
|
|
|
| with repair of enterocele |
Pelvic organ prolapse/stress
|
Major
|
|
|
urinary incontinence
|
|
||
| Vaginal hysterectomy; radical |
Pelvic organ prolapse with
|
Major
|
|
| (Schauta type operation) |
associated cervical cancer
|
|
|
| Uterine suspension, with or w/o |
Pelvic organ prolapsed
|
Major
|
|
| shortening of round ligaments, |
|
|
|
| with or w/o shortening of |
|
|
|
| sacrouterine ligaments; |
|
|
|
| Hysterorrhaphy, repair of ruptured |
Non-obstetrical uterine
|
Major
|
|
| uterus (nonobstetrical) |
rupture (e.g., trauma)
|
|
|
| Hysteroplasty, repair of uterine |
Mullerian anomalies, e.g.,
|
Major
|
|
| anomaly (Strassman type) |
Septate uterus
|
|
|
| Laparoscopy, surgical, |
Uterine pathologies
|
Major
|
|
| myomectomy, excision; intramural |
|
|
|
| myomas and/or removal of |
|
|
|
| surface myomas |
|
|
|
| Laparoscopy surgical, with vaginal |
Uterine pathologies
|
Major
|
|
| hysterectomy; with removal of |
|
|
|
| tube(s) and/or ovary(s) |
|
|
|
| Hysteroscopy diagnostic |
Uterine pathologies
|
Minor
|
|
| Hysteroscopy, surgical; with |
Uterine pathologies
|
Minor
|
|
| sampling (biopsy) of endometrium |
|
|
|
| and/or polypectomy, with or w/o |
|
|
|
| D & C |
|
|
|
| with lysis of intrauterine |
Uterine pathologies
|
Minor
|
|
| adhesions (any method) |
|
|
|
| with division or resection of |
Uterine pathologies
|
Minor
|
|
| intraterine septum (any method) |
|
|
|
| with removal of leiomyomata |
Uterine pathologies
|
Minor
|
|
| with removal of impacted |
Uterine pathologies
|
Minor
|
|
| foreign body |
|
|
|
| with endometrial ablation (e.g., |
Uterine pathologies
|
Minor
|
|
| endometrial resection, |
|
|
|
| electrosurgical ablation |
|
|
|
| thermoablation) |
|
|
|
| with bilateral fallopian tube |
Uterine pathologies
|
Minor
|
|
| cannulation to induce occlusion |
|
|
|
| by placement of permanent |
|
|
|
| implants |
|
|
|
| Laparoscopy, surgical; with lysis of |
Fallopian tube pathologies
|
Minor
|
|
| adhesions (salphingolysis) |
|
|
|
| with removal of adnexal |
Fallopian tube pathologies
|
Major
|
|
| structures (partial or total |
|
|
|
| oophorectomy and/or |
|
|
|
| salpingectomy |
|
|
|
| with fulguration or excision of |
Fallopian tube pathologies
|
Minor
|
|
| lesions of the ovary, pelvic |
|
|
|
| viscera, or peritoneal surface |
|
|
|
| by any method |
|
|
|
| with fulguration of oviducts |
Fallopian tube pathologies
|
Minor
|
|
| (with or without transection) |
|
|
|
| with occlusion of oviducts by |
Fallopian tube pathologies
|
|
|
| device (e.g., band, clip, or |
|
|
|
| Falope ring) |
|
|
|
| with fimbrioplasty |
Fallopian tube pathologies
|
Major
|
|
| with salphingostomy |
Fallopian tube pathologies
|
Major
|
|
| (salpingoneostomy) |
|
|
|
| Oviduct |
|
|
|
|
Procedure
|
Disease
|
Classification
|
|
| Tubal Reanastomosis |
Fallopian tube pathologies
|
Major
|
|
| Salpingectomy, complete or |
Fallopian tube pathologies
|
Major
|
|
| partial, unilateral or bilateral |
|
|
|
| Salphingo-oophorectomy, complete |
Fallopian tube and ovarian
|
Major
|
|
| or partial, unilateral or bilateral |
pathologies
|
|
|
| Lysis of adhesions (salpingolysis) |
Fallopian tube pathologies
|
Major
|
|
| Fimbrioplasty |
Fallopian tube pathologies
|
Major
|
|
| Salpingostomy (salpingoneostomy) |
Fallopian tube pathologies
|
Major
|
|
| Transcervical introduction of |
Fallopian tube pathologies
|
Major
|
|
| fallopian tube catheter for |
|
|
|
| diagnosis and/or re-establishing |
|
|
|
| patency (any method) with or w/o |
|
|
|
| hysterosalpingogrophy |
|
|
|
| Ovary |
|
|
|
|
Procedure
|
Disease
|
Classification
|
|
| Aspiration of ovarian cyst(s), |
Ovarian cyst
|
Minor
|
|
| unilateral or bilateral; vaginal |
|
|
|
| approach |
|
|
|
| Drainage of ovarian abscess; |
Tuboovarian abscess
|
Minor
|
|
| vaginal approach |
|
|
|
| Ovarian cystectomy, unilateral or |
Benign ovarian cysts (e.g.,
|
Major
|
|
| bilateral |
endometriotic cyst, dermoid
|
|
|
|
cyst, serous cystadenoma,
|
|
||
|
mucinus cystadenoma)
|
|
||
| Oophorectomy, partial or total, |
Benign ovarian cysts
|
Major
|
|
| unilateral or bilateral; |
|
|
|
| For ovarian malignancy, with para- |
Ovarian cancer
|
Major
|
|
| aortic and pelvic lymph node |
|
|
|
| biopsies, peritoneal washings, |
|
|
|
| peritoneal biopsies, diaphragmatic |
|
|
|
| assessments, with or w/o |
|
|
|
| salpingectomy(s), with or w/o |
|
|
|
| peritoneal biopsies, diaphragmatic |
|
|
|
| assessments, with or w/o |
|
|
|
| salpingectomy(s), with or w/o |
|
|
|
| omentectomy |
|
|
|
| Resection of ovarian malignancy with |
Ovarian cancer
|
Major
|
|
| bilateral salpingo-oophorectomy |
|
|
|
| and omentectomy; |
|
|
|
| with total abdominal |
Ovarian cancer
|
Major
|
|
| hysterectomy, pelvic and |
|
|
|
| limited para-aortic |
|
|
|
| lymphadenectomy |
|
|
|
| with radical dissection for |
Ovarian cancer
|
Major
|
|
| debulking |
|
|
|
| Laparotomy, for staging or |
Ovarian cancer
|
Major
|
|
| restaging of ovarian malignancy |
|
|
|
| ("second look"), with or w/o |
|
|
|
| omentectomy, peritoneal washing, |
|
|
|
| biopsy of abdominal and pelvic |
|
|
|
| peritoneum, diaphragmatic |
|
|
|
| assessment with pelvic and |
|
|
|
| limited para-aortic |
|
|
|
| lymphadenectomy |
|
|
|
| Ovariolysis |
Lysis of Adhesions
|
Major
|
|
| Breast Procedures |
|
|
|
|
Procedure
|
Disease
|
Classification
|
|
| Puncture aspiration of cyst of |
Simple breast cyst,
|
Minor
|
|
| breast |
Fibrocystic change
|
|
|
| Mastotomy with exploration or |
Breast abscess/Mastitis
|
Minor
|
|
| drainage of abscess, deep |
|
|
|
| Biopsy breast; needle core, fine |
Breast mass, benign or
|
Minor
|
|
| needle aspiration |
malignant
|
|
|
| Excision of lactiferous duct fistula |
Intraductal Papilloma
|
Minor
|
|
| Excision of cyst, fibroadenoma, |
Fibroadenoma, Fibrocystic
|
Minor
|
|
| or other benign breast masses |
change
|
|
|
| Incision/Excision biopsy |
Benign breast masses or
|
Minor
|
|
|
breast cancer
|
|
||
| Wide excision |
Phyllodes tumor, Ductal
|
Major
|
|
|
carcinoma in-situ, Lobular
|
|
||
|
carcinoma in-situ
|
|
||
| Total Mastectomy |
Phyllodes tumor, Ductal
|
Major
|
|
|
carcinoma in-situ, Lobular
|
|
||
|
carcinoma in-situ
|
|
||
| Mastectomy, subcutaneous |
Silicone Mastitis
|
Major
|
|
| Radical/Modified Radical |
Breast cancer
|
Major
|
|
| Mastectomy |
|
|
|
| Lumpectomy/quadrantectomy, |
Breast cancer
|
Major
|
|
| axillary node dissection |
|
|
|
| Lumpectomy, sentinel node |
Breast cancer
|
Major
|
|
| biopsy +/- axillary node |
|
|
|
| dissection |
|
|
|
| Breast reconstruction with |
Breast cancer, Phyllodes
|
Major
|
|
| latissimus dorsi flap, with or |
tumor, Ductal carcinoma in-
|
|
|
| without prosthetic implant |
situ, lobular carcinoma in-
|
|
|
|
situ (after mastectomy)
|
|
||
| Breast reconstruction with |
Breast cancer, Phyllodes
|
Major
|
|
| free flap |
tumor, Ductal carcinoma in-
|
|
|
|
situ, lobular carcinoma in-
|
|
||
|
situ (after mastectomy)
|
|
||
| Breast reconstruction with |
Breast cancer, Phyllodes
|
Major
|
|
| other technique |
tumor, Ductal carcinoma in-
|
|
|
|
situ, lobular carcinoma in-
|
|
||
|
situ (after mastectomy)
|
|
||
| Breast reconstruction with |
Breast cancer, Phyllodes
|
Major
|
|
| transverse rectus abdominis |
tumor, Ductal carcinoma in-
|
|
|
| myocutaneous flap (TRAM) |
situ, lobular carcinoma in-
|
|
|
|
situ (after mastectomy)
|
|
Legend:
* Classification refers to the estimated period of one's recuperation after
Minor — pertains to one's estimated period of recuperation requiring a
Major — pertains to one's estimated period of recuperation more than three